Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
THDBH-150 by Tonghua Dongbao Pharmaceutical for Hyperuricemia: Likelihood of Approval
THDBH-150 is under clinical development by Tonghua Dongbao Pharmaceutical and currently in Phase I for Hyperuricemia. According to GlobalData, Phase...
Data Insights
THDBH-150 by Tonghua Dongbao Pharmaceutical for Gouty Arthritis (Gout): Likelihood of Approval
THDBH-150 is under clinical development by Tonghua Dongbao Pharmaceutical and currently in Phase I for Gouty Arthritis (Gout). According to...